v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities        
Net loss $ (10,171) $ (8,284) $ (36,461) $ (39,661)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:        
Depreciation and amortization 1,740 1,961 7,215 6,246
Stock-based compensation 3,362 851 6,835 5,174
Gain on receipt of nonmonetary tangible assets 0 (1,600) (1,600) (1,600)
Change in right-of-use assets 209 242 698 987
Non-cash issuance of warrants     0 1,940
Change in warrant valuations and cancellations 0 (58) 60 (51)
Inventory valuation adjustment     199 428
Other     (110) 0
Changes in operating assets and liabilities        
Accounts receivable (3,644) 6,349 3,226 1,754
Inventories (6,526) (286) (2,128) 6,041
Prepaid expenses and other assets 745 66 (844) 521
Other long-term assets (3) 0 (344) 0
Accounts payable 2,142 2,255 2,859 821
Accrued and other current liabilities 885 (90) 1,022 (3,565)
Other long-term liabilities 88 0 (317) (463)
Net cash (used in) provided by operating activities (11,173) 1,406 (19,690) (21,428)
Cash flows from investing activities        
Purchase of intangible assets (3,437) (1,000) (6,099) (3,073)
Purchases of property, equipment and software (584) (116) (1,344) (658)
Net cash used in investing activities (4,021) (1,116) (7,443) (3,731)
Cash flows from financing activities        
Proceeds from issuance of common stock in connection with follow-on offering, net of underwriting discounts and commissions 76,832 0 102,672 0
Payment of deferred offering costs (1,488) 0 (2,829) 0
Proceeds from issuance of preferred stock, net of issuance costs     0 57,989
Proceeds from exercise of stock options 1,090 148 839 854
Proceeds from exercise of warrants 3,010 0 5,702 0
Net cash provided by financing activities 79,444 148 106,384 58,843
Effect of exchange rate changes on cash and cash equivalents 10 (1) 43 (24)
Net increase in cash and cash equivalents 64,260 437 79,294 33,660
Cash and cash equivalents at beginning of period 140,275 60,981 60,981 27,321
Cash and cash equivalents at end of period 204,535 61,418 140,275 60,981
Supplemental disclosure of non-cash investing and financing activities        
Intangible assets in accounts payable, accrued and other long-term liabilities 7,536 6,004 9,764 10,328
Gain on receipt of nonmonetary tangible asset 0 1,600 1,600 1,600
Right-of-use assets obtained in exchange for new operating lease liabilities $ 1,237 $ 383 382 1,207
Non-cash deferred offering costs     $ (300) 0
Deemed dividends       $ 2,724